key: cord-1022218-21ri2xtz authors: Mohammed, Hamzah title: Recognizing African‐American contributions to neurology: The role of Solomon Carter Fuller (1872–1953) in Alzheimer's disease research date: 2020-12-15 journal: Alzheimers Dement DOI: 10.1002/alz.12183 sha: 8873d07e48d718c648cf8971e3b77a10b619dff2 doc_id: 1022218 cord_uid: 21ri2xtz Solomon Carter Fuller (1872–1953) is widely acknowledged as the first African‐American psychiatrist but underappreciated as a pioneer of Alzheimer's disease. He immigrated to the United States from Liberia at age 17 and excelled in his medical career to become associate professor of both pathology and neurology at Boston University by 1921. He was one of five research assistants selected by Alois Alzheimer to work in his laboratory at the Royal Psychiatric Hospital in Munich, an experience that arguably paved the way for trailblazing research in Alzheimer's disease. Dr Fuller was the first to translate much of Alzheimer's pivotal work into English, including that of Auguste Deter, the first reported case of the disease. He published what is now recognized to be the first comprehensive review of Alzheimer's disease, in it reporting the ninth case ever described. His achievements, in a period when African‐American physicians were under‐represented, merit greater recognition. Racial inequality remains a considerable problem in society worldwide. For Black and African-American individuals, it is a sobering and painful reality that has persisted for almost six decades since the Civil Rights Act was passed in 1964. However, in recent months, a rising crescendo of protest against racial discrimination has emerged in the United States and internationally. It has become a modern-day social renaissance, not only seeking to bridge the gap between races but also to rediscover and recognize previously neglected Black, Asian and minority ethnic (BAME) influences in society. Medicine is no exception: The role of BAME physicians in pioneering disease research is rich but relatively under-recognized in modern medical literature. Dr Solomon Carter Fuller, the focus of this article, is widely acknowledged as the first African-American psychiatrist and, alongside his contemporary Alois Alzheimer, a trailblazer of dementia research. Yet at the time of writing (August 4, 2020), a simple PubMed from their date of inception to August 2020, with selected references exported and formatted using EndNote X9. Specific search terms and Boolean search modifiers included "Solomon Carter Fuller" and "Solomon Fuller." No restrictions on language or publication date were placed. In 1907, following his return from Munich 2 years earlier, Fuller published a case series describing the neuropathological features on autopsy of patients diagnosed with conditions including "dementia paralytica", "dementia senilis," and chronic alcoholism. 9 In it he reported abnormal neuronal appearances and the presence of neurofibrils in cases of "dementia senilis" and "dementia paralytica", while also recog- reflective of neurofibrillary tangles. 14, 16 In the same year, Samuel Fuller and his colleague Henry Klopp described a case of suspected Alzheimer's disease that did not exhibit intracellular neurofibrils on autopsy, yet bore senile plaques and clinical similarities to previously diagnosed cases. 16, 17 In recognizing the case as "an example of the group now designated as Alzheimer's disease," Fuller and Klopp unequivocally accepted Alzheimer's disease as a clinical entity but stopped short of regarding it distinct from senile dementia altogether. 17, 18 To this end they judged Alzheimer's disease Beyond an Honorary Doctor of Science degree awarded by Liv- The latter half of the 19th century was witness to a period of enlightenment in neurology that was propelled by celebrated figures including William Gowers, John Hughlings Jackson, and Alois Alzheimer. Dr Fuller is another such figure but whose name and achievements have largely been ignored by the annals of history. Raised from humble beginnings in Liberia, Fuller overcame overwhelming odds in an environment hostile to African-American progress to become one of a select few to pioneer dementia research. His translation of Alzheimer's work, combined with his own observations, arguably enabled the concept of Alzheimer's disease as a novel clinical entity to spread throughout the English-speaking world. However, detail of Fuller's experiences in Germany are limited and merit further research. In addition to barriers to academic progression, they appear to suggest a reluctancy within society at the time to acknowledge African-American excellence in medicine. Solomon Carter Fuller was a father and husband, a keen gardener, and master bookbinder. For the scientific community, he was an outstanding physician who excelled in a country where his grandfather had been enslaved and obtained his freedom. His career trajectory may have been greater had he not been African American, yet this did not hold him back from becoming a pioneer in Alzheimer's disease research. Hamzah Mohammed https://orcid.org/0000-0001-5678-9758 1872-1953): American pioneer in Alzheimer's disease research 1847-1918 first Afro-American women physician in New York State Voices of Historical and Contemporary Black American: Pioneers East European Jewish Immigrants and the New York City epidemics of 1892 Research WEBDBIfA-A. African American Lives Nine Black American Doctors Solomon Carter Fuller-1872-1953 A study of the neurofibrils in dementia paralytica, dementia senilis, chronic alcoholism, cerebral lues and microcephalic idiocy Dementia reimagined: building a life of joy and dignity from beginning to end What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages A study of the miliary plaques found in brains of the aged Alzheimer's disease Alzheimer's disease (senium praecox): the report of a case and review of published cases Alzheimer's disease (senium praecox): the report of a case and review of published cases Solomon Carter Fuller (1872-1953) and the early history of Alzheimer's disease Further observations on Alzheimer's disease Self, senility, and Alzheimer's disease in modern America: a history The African American Experience: Psychoanalytic Perspectives New evidence regarding racial and ethnic disparities in mental health: policy implications. Health Aff (Millwood) The quality of care for depressive and anxiety disorders in the United States Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care Social and psychological consequences of the COVID-19 pandemic in African-American communities: lessons from Michigan National society of black S. Edward Bouchet: The First African-American Doctorate Schomburg Center for Research in Black Culture; 1968. How to cite this article: Mohammed H. Recognizing African-American contributions to neurology Alzheimer's disease research